Illustrative image – not actual.Bharat Biotech has announced the acquisition of Chiron Behring Vaccines from GlaxoSmithKline Asia. The Chiron Behring Vaccines is located in Ankleshwar, Gujarat.
The company will acquire 100 percent equity stake in Chiron Behring Vaccines in an all-cash transaction, subject to a number of closing conditions which Bharat Biotech and GSK intend to complete in coming weeks.
Chiron Behring Vaccines was formed as a result of the purchase of the vaccines business of Hoechst AG by Chiron Corporation USA. It is one of the largest manufacturers of high quality rabies vaccines in the world.
The company has a wide portfolio of vaccines, with market access to more than 70 countries. Bharat Biotech intends to enhance the manufacturing capabilities at Chiron Behring Vaccines and expand market access through product registrations in additional high demand countries.
The company will acquire 100 percent equity stake in Chiron Behring Vaccines in an all-cash transaction, subject to a number of closing conditions which Bharat Biotech and GSK intend to complete in coming weeks.
Chiron Behring Vaccines was formed as a result of the purchase of the vaccines business of Hoechst AG by Chiron Corporation USA. It is one of the largest manufacturers of high quality rabies vaccines in the world.
The company has a wide portfolio of vaccines, with market access to more than 70 countries. Bharat Biotech intends to enhance the manufacturing capabilities at Chiron Behring Vaccines and expand market access through product registrations in additional high demand countries.
